Belvedere Trading
EVLO

Belvedere Trading’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Belvedere Trading’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,035
Closed -$256K – 644
2021
Q2 		$256K Buy
+1,035
New +$261K 0.02% 169

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Belvedere Trading's EVLO Position: Q2 2022 in Review

Belvedere Trading sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 8,640 shares — an estimated $397K sold.

Belvedere Trading first reported a position in EVLO in Q3 2021 and held it in 3 quarters. The position peaked at $1.18M in Q4 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • Belvedere Trading reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 8,640 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $397K.
  • Belvedere Trading first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Belvedere Trading's Evelo Biosciences, Inc. Common Stock position peaked at $1.18M in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.